Drug Profile
Research programme: PPAR agonists - DARA Biosciences
Alternative Names: DB900 series; Peroxisome proliferator activated receptor agonists; PPAR agonists - DARALatest Information Update: 17 Feb 2012
Price :
$50
*
At a glance
- Originator Bayer HealthCare Pharmaceuticals
- Developer Fortovia Therapeutics
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists; Peroxisome proliferator-activated receptor delta agonists; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- Suspended Type 2 diabetes mellitus
Most Recent Events
- 15 Feb 2012 Research programme: PPAR agonists - DARA Biosciences is available for licensing as of 15 Feb 2012. http://www.darabio.com
- 30 Mar 2010 Suspended - Preclinical for Type-2 diabetes mellitus in USA (unspecified route)